Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Lymphoma, T-Cell, Peripheral × VAP-cyclo protocol × Clear all

Phase

Phase 4 2 Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, T-Cell, Peripheral 1

Interventions

Peripheral Blood Stem Cell Transplantation 3 Whole-Body Irradiation 2 Mycophenolic Acid 2 Etoposide 2 Drug Therapy 2 Cyclosporine 2 plerixafor 1 monomethyl auristatin E 1 fludarabine phosphate 1 Vinorelbine 1 VAP-cyclo protocol 1 O(6)-benzylguanine 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Melphalan 1 Leukapheresis 1 Immunoconjugates 1 Granulocyte Colony-Stimulating Factor 1 Gemcitabine 1 Filgrastim 1 Cytarabine 1 Carmustine 1 Brentuximab Vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03268889 2017-08-31

CHOP

The First Affiliated Hospital of Soochow University

Phase NA Unknown

Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡